![Carlos Campoy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carlos Campoy
Director/Board Member at
ZYMEWORKS INC.
Net worth: - $ as of 2026-07-30
Profile
Mr. Carlos E.
Campoy is an Independent Director at Zymeworks, Inc. He is on the Board of Directors at Zymeworks, Inc. and Zymeworks BC, Inc. Mr. Campoy was previously employed as a Chief Financial Officer & Senior Vice President by CytomX Therapeutics, Inc., a Chief Financial Officer by Alder Biopharmaceuticals, Inc., a Partner by Think Forwards, a Vice President-International Finance by Allergan Ltd. (Ireland), and a Chief Financial Officer by Eli Lilly Japan KK.
He also served on the board at TP Orthodontics, Inc. He received his undergraduate degree from Faculdades Faccat and an MBA from Indiana University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZYMEWORKS INC. -.--% | 2026-01-11 | 0 ( -.--% ) | - $ | 2026-07-30 |
Carlos Campoy active positions
| Companies | Position | Start |
|---|---|---|
| ZYMEWORKS INC. | Director/Board Member | 2023-06-29 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Director/Board Member | - |
Former positions of Carlos Campoy
| Companies | Position | End |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 2022-09-29 |
| ALDER BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-10-31 |
Think Forwards | Corporate Officer/Principal | 2018-11-30 |
| ALLERGAN PLC | Corporate Officer/Principal | 2016-10-31 |
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Director of Finance/CFO | 2014-06-30 |
Training of Carlos Campoy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
56
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Eli Lilly Japan KK
Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Health Technology |
TP Orthodontics, Inc.
 TP Orthodontics, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes orthodontic products | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Faculdades Faccat
 Faculdades Faccat Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Think Forwards | |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Carlos Campoy
